Palladium catalysis in the synthesis of medicinal agents

Current Opinion in Drug Discovery and Development

Volumn 2, Issue 6, 1999, Pages 651-667

  Larsen, Robert D ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Asymmetric synthesis; Carbon carbon coupling; Carbon nitrogen bond formation; Carbonylation; Heterocycles; Palladium catalysis

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; 3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 3 ETHYNYL 5 (1 METHYL 2 PYRROLIDINYL)PYRIDINE; 4 [2 [5,6 DIHYDRO 5,5 DIMETHYL 8 (4 METHYLPHENYL) 2 NAPHTHYL]ETHYNYL]BENZOIC ACID; 6 CHLORO 2 [(1 FURO[2,3 C]PYRIDIN 5 YLETHYL)THIO] 4 PYRIMIDINAMINE; ABACAVIR; ANTIPARKINSON AGENT; ARIPIPRAZOLE; ARZOXIFENE; BENZOTHIOPHENE; CARBAPENEM; CARBOVIR; CEPHALOSPORIN DERIVATIVE; CYCLOOXYGENASE 2 INHIBITOR; ENRASENTAN; EPRISTERIDE; L 742728; L 786392; LINTITRIPT; NORASTEMIZOLE; OXIDOREDUCTASE INHIBITOR; PALLADIUM; RALOXIFENE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SB 209953; THROMBIN INHIBITOR; THROMBOXANE RECEPTOR AFFECTING AGENT; UK 147535; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CATALYSIS; CHEMICAL BOND; CHEMICAL REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR INTERACTION; REVIEW;

EID: 0032735203     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Suzuki A: Recent advances In the cross-coupling reactions of organoboron derivatives with organic electrophiles, 1995-1998. J Organomet Chem (1999) 576:147-168. •• TOs is an excellent review of the recent literature concerning the Suzuki-Miyaura coupling.
2. Larsen RD, King AO, Chen CY, Corley EG, Foster BS, Roberts FE, Yang C, Lieberman DR, Reamer RA, Tschaen DM, Verhoeven TR, Reider PJ, Lo YS, Rossano LT, Brookes AS, Meloni D, Moore JR, Amett JF: Efficient synthesis of losartan, a nonpeptide angiotensin II receptor antagonist. J Org Chem (1994) 59:6391-6394.
3. Chen CY, Lieberman DR, Larsen RD, Reamer RA, Verhoeven TR, Reider PJ, Cottrell IF, Houghton PG: Synthesis of the 5HT1D receptor agonist MK-0462 via a Pd-catalyzed coupling reaction. Tetrahedron J.erf (1994) 35:6981-6984.
4. Larock RC: Palladium-catalyzed annulation. J Organomet Chem (1999) 576:111-124. •• A class of reaction that has had a significant impact on heterocyclic synthesis.
5. Yang BH, Buchwald SL: Palladium-catalyzed amlnation of aryl halides and sulfonates. J Organomet Chem (1999) 576:125-146. •• Important review of the advances in carbon-nitrogen couplings.
6. Yamamoto Y, Negishi (Eds): J Organomet Chem (1999) 576 (1-2):xi-318. ••This issue is a collection of review articles covering many of the active areas of study concerning palladium reactions as a synthetic method.
7. Negishi E: A profile of Professor Richard F Heck: Discovery of the Heck Reaction. J Organomet Chem (1999) 576:xv-xvi. •• Details one of the true landmark reactions in organic chemistry.
8. Dack KN, Dickinson RP, Long CJ, Steele J: Thromboxane modulating agents. 4. Design and synthesis of 3-(2-[((4-chlorophenyl)sulfonyl))-amino]ethyl)benzenepropanoic acid derivatives as potent thromboxane receptor antagonists. Bioorg Med Chem Lett (1998) 8:2061-2066.
9. Johnson AT, Wang L, Gillett SJ, Chandraratna RAS: High affinity retinoic acid receptor antagonists: analogs of AGN 193109. Bioorg Med Chem Lett (1999) 9:573-576.
10. Smith III AB, On GR: Total syntheses of (-)-macrolactin A, (+)-macrolactin E, and (-)-macrolactinic acid: an exercise in Stille cross-coupling chemistry. J Am Chem Soc (1998) 120:3935-3948. • This total synthesis demonstrates the impact that palladiumcatalyzed reactions can have on the efficient construction of complex natural products.
11. Clark WM, Tickner-Eldridge AM, Huang GK, Pridgen LN. Olsen MA, Mills RJ. Lantos I, Baine NH: A catalytic enantioselective synthesis of the endothelin receptor antagonists SB-209670 and SB-217242. A base-catalyzed stereospecific formal 1,3-hydrogen transfer of a chiral 3arylindenol. JAm Chem Soc (1998) 120:4550-4551.
12. Pridgen LN, Huang GK: An optimized palladium catalyzed cross-coupling of nonracemic trifluoromethylsulfonyl and fluorosulfonyl enol ethers to arylboronic acids. Tetrahedron f.eff (1998) 39:8421-8424.
13. Curtis NR, Kulagowski JJ, Leeson PD, Ridgill MP, Emms F, Freedman SB, Patel S, Pate) S: Synthesis and SAR of 2- and 3-substituted 7-azaindoles as potential dopamine D, ligands. Bioorg Med Chem Lett (1999) 9:585-588.
14. Ujjainwalla F, Warner D: Synthesis of 5-, 6- and 7-azaindoles via palladium-catalyzed heteroannulation of internal alkynes. Tetrahedron J.e(1998) 39:5355-5358. • The paper is a good adjunct to preparing a variety of azaindoles.
15. Xu L, Lewis IR, Davidsen SK, Summers JB: Transition metal catalyzed synthesis of 5-azaindoles. Tetrahedron J.eft (1998) 39:5159-5162. • The paper is a good adjunct to preparing a variety of azaindoles.
16. Wishka DG, Graber DR, Kopta LA, Olmsted RA, Friis JM, Hosley JD, Adams WJ, Seest EP, Castle TM, Dolak LA, Keiser BJ, Yagi Y, Jeganathan A, Schlachter ST, Murphy MJ, Cleek GJ, Nugent RA, Poppe SM, Swaney SM, Man F, Watt W, White WL, Poel TJ, Thomas RC, Voorman RL, Stefanski KJ, Stehle RG, Tarpley WG, Morris J: (-)-6-Chloro-2-[(1-furo[2,3c]pyridin-5-ylethyl)thio]-4-pyrimidinamine, PNU-142721, a new broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitor. J Med Chem (1998) 41:1357-1360.
17. Wishka DG, Graber DR, Seest EP, Dolak LA, Han F, Watt W, Morris J: Stereoselective synthesis of furo[2,3-c]pyridine pyrimidine thioethers, a new class of potent HIV-1 nonnucleoside reverse transcriptase Inhibitors. J Org Chem (1998)63:7851-7859.
18. Morita S, Kitano K, Matsubara J, Ohtani T, Kawano Y, Otsubo K, Uchida M: Practical application of the palladiumcatalyzed amination in phenylpiperazine synthesis: an efficient synthesis of a metabolite of the antipsychotic agent aripiprazole. Tetrahedron (1998) 54:4811-4818.
19. Graul A, Leeson PA, Castaner J: Abacavir sulfate. Drugs Future (1998) 23:1155-1167.
20. Kapeller H, Marschner C, Weissenbacher M, Griengl H: Synthesis of cyclopentenyl carbanucleosides via palladium(O) catalysed reactions. Tetrahedron (1998) 54:1439-1456.
21. Olivo HF, Yu J: Practical enantiodivergent syntheses of both enantiomers of carbovir, 15921)89 and six-membered ring analogues. J Chem Soc Perkin Trans 1 (1998):391-392.
22. Lakshman MK, Keeler JC, Hilmer JH, Martin JQ: Palladiumcatalyzed C-N bond formation: facile and general synthesis of A/-aryl 2'-deoxyadenosine analogues. J Am Chem Soc (1999) 121:6090-6091.
23. Handley DA, Hong Y, Bakale R, Senanayake C: Norastemizole. Drugs Future (1998) 23:966-969.
24. Hong Y, Senanayake CH, Xiang T, Vandenbossche CP, Tanoury GJ, Bakale RP, Wald SA: Remarkably selective palladium-catalyzed amination process: rapid assembly of multiamino based structures. Tetrahedron Lett (1998) 39:3121-3124.
25. Gordon DW: An improved synthesis of YC-1. Synlett (1998):1065-1066.
26. Collot V, Dallemagne P, Bovy PR, Rault S: Suzuki-type cross-coupling reaction of 3-lodoindazoles with aryl boronic acids: a general and flexible route to 3arylindazoles. Tetrahedron (1999) 55:6917-6922.
27. Bradley DA, Godfrey AG, Schmid CR: Synergistic methodologies for the synthesis of 3-aroyl-2arylbenzo[b]thiophene-based selective estrogen receptor modulators. Two concise syntheses of raloxifene. Tetrahedron J.eff (1999) 40:5155-5159.
28. Bastian JA, Chirgadze N, Denney ML, Gifford-Moore DS, Sail DJ, Smith GF, Wikel JH: Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 3. Enhancing activity by imposing conformational restriction in the C-4" side chain. Bioorg Med Chem Lett (1999) 9:363-368.
29. Takeuchi K, Kohn TJ, Sail DJ, Denney ML, McCowan JR, Smith GF, Gifford-Moore DS: Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 4. SAR studies on the conformationally restricted C-3 side chain of hydroxybenzo[b]thiophenes. Bioorg Med Chem Lett (1999)9:759-764.
30. Rabasseda X, Leeson PA, Castaner J: Arzoxifene hydrochloride. Drugs Future (1999) 24:599-604.
31. Yasuda N, Huffman MA, Ho GJ, Xavier LC, Yang C, Emerson KM, Tsay FR, Li Y, Kress MH, Rieger DL, Karady S, Sohar P, Abramson NL, DeCamp AE, Mathre DJ, Douglas AW, Dolling UH, Grabowski EJ, Reider PJ: Practical synthesis of antimethicillin-resistant staphylococcus aureus (MRS A) carbapenem L-742,728. J Org Chem (1998) 63:5438-5446.
32. Yasuda N, Yang C, Wells KM, Jensen MS, Hughes DL: Preparation of crystalline p-nitrobenzyl 2-hydroxymethyl carbapenem as a key Intermediate for the anti-MHS carbapenem L-786,392. Tetrahedron Lett (1999) 40:427-430.
33. Dykstra KD, DiNinno F: The syntheses of functionalized 2-alkenyl and alkynyl-1-/J-methyl-carbapenems via the Stille cross-coupling reaction. Tetrahedron Lett (1998) 39:1865-1868.
34. Buynak JD, Doppalapudi VR, Frotan M, Kumar R: Stille coupling approaches to the stereospecific synthesis of 7-[(£)-alkyIidene]cephalosporins. Tetrahedron Lett (1999) 40:1281-1284.
35. Bleicher LS, Cosford NDP, Herbaut A, McCallum JS, McDonald IA: A practical and .efficient synthesis of the selective neuronal acetylcholine-gated ion channel agonist (S)-(-)-5-ethynyl-3-(1 -methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y). J Org Chem (1998) 63:1109-1118.
36. Friesen RW, Brideau C, Chan CG, Charleson S, Deschenes D, Dube D, Ethier D, Fortin R, Gauthier JY, Girard Y, Gordon R, Greig GM, Riendeau D, Savoie C, Wang Z, Wong E, Visco D, Xu U, Young RN: 2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitors. Bioorg Med Chem Lett (1998) 8:2777-2782.
37. Dube D, Brideau C, Deschenes D, Fortin R, Friesen RW, Gordon R, Girard Y, Riendeau D, Savoie C, Chan CC: 2Heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridines as selective and orally active cyclooxygenase-2 inhibitors. Bioorg Med Chem Lett (1999) 9:1715-1720.
38. Pinto DJP, Ball DG, Pitts WJ, Petraitis JJ, Orwat MJ, Wang S, Jetter JW, Sherk SR, Houghton GC, Copeland RA, Covington MB, Trzaskos JM, Magolda RL: Terphenyl cyclooxygenase-2 (COX-2) inhibitors: optimization of the central ring and o-biphenyl analogs. Bioorg Med Chem Lett (1999) 9:919-924.
39. Yu MS, Baine NH: Synthesis of 3-carboxy-20-keto steroid, SB 209963, a 5a-reductase inhibitor, by palladiumcatalyzed hydroxycarbonylation. Tetrahedron Left (1999) 40: 3123-3124.
40. McGuire, MA, Sorenson E, Klein DN, Baine NH: Palladium and nickel catalyzed hydroxycarbonylation of a steroidal bromodiene in the synthesis of episteride, a potent 5orreductase inhibitor. Synth Commun (1998) 28:1611-1615.
41. Herbert JM, McNeill AH: Preparation of indole-2carboxamides by palladium-catalysed carbonylation.Tetrahedron Lett (1998) 39:2421-2424.
42. Bio MM, Leighton JL: An approach to the synthesis of CP263,114: a remarkably facile silyloxy-Cope rearrangement J Am Chem Soc(1999) 121:890-891.
43. Cobb JE, Blanchard SG, Boswell EG, Brown KK, Charifson PS, Cooper JP, Collins JL, Dezube M, Henke BR, Hull-Ryde EA, Lake DH, Lenhard JM, Oliver, Jr W, Oplinger J, Pentti M, Parks DJ, Plunket KD, Tong WQ: W-(2-Benzoylphenyl)-Ltyrosine PPARy agonists. 3. Structure-activity relationship and optimization of the W-aryl substituent. J Med Chem (1998)41:5055-5069.
44. Epibatidine. Drugs Future (1998) 23:1243.
45. Namyslo JC, Kaufmann DE: Asymmetric synthesis of both enantiomers of /V-protected epibatidine via reductive Hecktype hetarylation. Synlett (1999):804-806.
46. Namyslo JC, Kaufmann DE: Chemistry in the ambient field of the alkaloid epibatidine 2: triphenylarsine as an efficient ligand in the Pd-catalyzed synthesis of epibatidine and analogs. Synteff(1999):114-116.
47. Tang XC, He XC, Bai DL: Huperzine A: a novel acetylcholinesterase inhibitor. Drugs Future (1999) 24:647-663.
48. Campiani G, Kozikowski AP, Wang S, Ming L, Nacci V, Saxena A, Doctor BP: Synthesis and anticholinesterase activity of huperzine A analogues containing phenol and catechol replacements for the pyridone ring. Bioorg Med Chem Lett (1998)8:1413-1418.
49. He XC, Wang B, Bai D: Studies on asymmetric synthesis of huperzine A. 1. Palladium-catalyzed asymmetric bicycloannulation of 5,6,7,8-tetrahydro-2-methoxy-6-oxo-5quinolinecarboxylic esters. Tetrahedron Lett (1998) 39:411414.
50. Trost BM, Toste FD: Palladium-catalyzed kinetic and dynamic kinetic asymmetric transformation of 5-acyloxy-2(5H)-furanone. Enantioselective synthesis of (-)-aflatoxin B lactone. JAm Chem Soc(1999) 121:3543-3544. • An excellent example of the role palladium reactions can play as a linchpin in the synthesis of medicinal agents and natural products.
51. Corbett JW: Recent progress in solid phase heterocycle syntheses. A review. Org Prep Proc Int (1998) 30:489-550.
52. Lorsbach BA, Kurth MJ: Carbon-carbon bond forming solidphase reactions. Chem Rev(1999) 99:1549-1581.
53. Wang Y, Huang TN: Solid-phase synthesis of heterocycles via palladium-catalyzed annulation. Tetrahedron Lett (1998) 39:9605-9608.
54. Thompson LA, Moore FL, Moon YC, Ellman JA: Solid-phase synthesis of diverse E- and F-series prostaglandins. J Org Chem (1998) 63:2066-2067. • Example of how palladium catalysis can assist in building diversity in complex medicinal agents.